Cargando…
Duration of symptom control following intratympanic dexamethasone injections in Meniere’s disease
PURPOSE: Intratympanic (IT) injections of corticosteroids have emerged as a non-ablative alternative to gentamicin in the management of refractory Meniere’s disease. However, currently, the duration of the symptom control achieved via intratympanic corticosteroids is under reported. METHODS: We retr...
Autores principales: | Hilton, Aidan, McClelland, Alison, McCallum, Rhona, Kontorinis, Georgios |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9519661/ https://www.ncbi.nlm.nih.gov/pubmed/35397703 http://dx.doi.org/10.1007/s00405-022-07368-w |
Ejemplares similares
-
Intratympanic gentamycine for Ménière’s disease: is there a selective vestibulotoxic effect?
por: Molnár, András, et al.
Publicado: (2020) -
Quality of life after intratympanic steroid injection for Ménière's disease
por: Schenck, Annejet A., et al.
Publicado: (2022) -
Long-term growth patterns of vestibular schwannomas after stereotactic radiotherapy: delayed re-growth
por: Conlan, Owen, et al.
Publicado: (2022) -
Therapeutic Effect of Intratympanic Injection of Dexamethasone plus Hyaluronic Acid on Patients with Meniere's disease
por: Rogha, Mehrdad, et al.
Publicado: (2019) -
Intratympanic Injection of Dexamethasone and Electrocochleographic Data in Cases of Definite One Sided Refractory Meniere’s Disease
por: Dabiri Satri, Sasan, et al.
Publicado: (2017)